Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in Taiwan

Fu-Shun YenJames Cheng-Chung WeiHei-Tung YipChii-Min HwuMing-Chih HouChih-Cheng Hsu2026-01-302026-01-302021-01-1010.1007/s12072-020-10122-1https://scholars.csmu.edu.tw/handle/123456789/4112[SDGs]SDG3Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in Taiwanjournal-article